Literature DB >> 28801781

Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review.

Michelle Matthews1,2, Rebecca Pollack3.   

Abstract

PURPOSE: Hematopoietic stem cell transplantation (HSCT) is a cure for sickle cell disease (SCD) but frequently results in permanent sterility. The complications associated with oocyte cryopreservation and risks of future pregnancy are increased in SCD patients. This case report discusses risk reduction strategies and includes a literature review of pregnancy after HSCT. CASE: A 23-year-old woman underwent ovarian stimulation for fertility preservation resulting in cancelation due to acute pain crisis. She underwent a successful oocyte retrieval after exchange transfusion to decrease her hemoglobin S to 30%. This is the second report of a pain crisis in a woman with SCD undergoing oocyte banking. CONCLUSION(S): Women with SCD undergoing fertility preservation may be at increased risk of complications from ovarian stimulation. Risks in pregnancy after HSCT should also be considered before proceeding with fertility preservation.

Entities:  

Keywords:  Fertility preservation; Pain crisis; Sickle cell disease; Stem cell transplantation

Mesh:

Year:  2017        PMID: 28801781      PMCID: PMC5699988          DOI: 10.1007/s10815-017-1008-1

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  24 in total

1.  Menstrual pattern in women with sickle cell anaemia and its association with sickling crises.

Authors:  W C Yoong; S M Tuck
Journal:  J Obstet Gynaecol       Date:  2002-07       Impact factor: 1.246

2.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

3.  Epidemiology: a moving target.

Authors:  Simon Pleasants
Journal:  Nature       Date:  2014-11-13       Impact factor: 49.962

4.  Unanticipated pregnancy with intrauterine growth retardation after radiation-induced ovarian failure. A case report.

Authors:  R A Hammer; P D Urnes; J R Lurain
Journal:  J Reprod Med       Date:  1996-05       Impact factor: 0.142

Review 5.  Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.

Authors:  Dana Shanis; Melissa Merideth; Tajana Klepac Pulanic; Bipin N Savani; Minoo Battiwalla; Pamela Stratton
Journal:  Semin Hematol       Date:  2012-01       Impact factor: 3.851

6.  Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

Authors:  Matthew M Hsieh; Courtney D Fitzhugh; R Patrick Weitzel; Mary E Link; Wynona A Coles; Xiongce Zhao; Griffin P Rodgers; Jonathan D Powell; John F Tisdale
Journal:  JAMA       Date:  2014-07-02       Impact factor: 56.272

Review 7.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

8.  Ovarian function after autologous bone marrow transplantation.

Authors:  A D Schimmer; M Quatermain; K Imrie; V Ali; J McCrae; A K Stewart; M Crump; C Derzko; A Keating
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544

Review 9.  Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future.

Authors:  M Bhatia; M C Walters
Journal:  Bone Marrow Transplant       Date:  2007-12-03       Impact factor: 5.483

10.  The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial.

Authors:  Jo Howard; Moira Malfroy; Charlotte Llewelyn; Louise Choo; Renate Hodge; Tony Johnson; Shilpi Purohit; David C Rees; Louise Tillyer; Isabeau Walker; Karin Fijnvandraat; Melanie Kirby-Allen; Eldon Spackman; Sally C Davies; Lorna M Williamson
Journal:  Lancet       Date:  2013-01-23       Impact factor: 79.321

View more
  5 in total

Review 1.  Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease.

Authors:  Emily Limerick; Allistair Abraham
Journal:  J Clin Med       Date:  2022-07-03       Impact factor: 4.964

Review 2.  Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care.

Authors:  Robert Sheppard Nickel; Jacqueline Y Maher; Michael H Hsieh; Meghan F Davis; Matthew M Hsieh; Lydia H Pecker
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.964

3.  Microencapsulated Schwann cell transplantation inhibits P2X3 receptor expression in dorsal root ganglia and neuropathic pain.

Authors:  Ya-Ling Zhang; De-Jian Chen; Bao-Lin Yang; Tao-Tao Liu; Jia-Juan Li; Xiu-Qi Wang; Guo-Yong Xue; Zeng-Xu Liu
Journal:  Neural Regen Res       Date:  2018-11       Impact factor: 5.135

4.  Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved.

Authors:  Linn Salto Mamsen; Stine Gry Kristensen; Susanne Elisabeth Pors; Jane Alrø Bøtkjær; Erik Ernst; Kirsten Tryde Macklon; Debra Gook; Ajay Kumar; Bhanu Kalra; Claus Yding Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-15       Impact factor: 5.555

5.  Fertility preservation before hematopoetic stem cell transplantation: a case series of women with GATA binding protein 2 deficiency, dedicator of cytokinesis 8 deficiency, and sickle cell disease.

Authors:  Alexandra Aserlind; Anne Martini; Jiawen Dong; Jessica Zolton; Olivia Carpinello; Alan DeCherney
Journal:  F S Rep       Date:  2020-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.